Revolution Medicines (RVMD) Stock: Buy, Sell, or Hold?
RVMD - Revolution Medicines, Inc. Common Stock
$205.89
0.63 (0.31%)
â˛
5d:
+3.02%
30d:
-1.9%
90d:
+8.8%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When RVMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: RVMD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: RVMD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: RVMD is currently trading at $205.89, which is considered fair relative to its 30-day fair value range of $197.33 to $211.77.
Technical Outlook: Technically, RVMD is in a strong uptrend. The price is approaching resistance at $211.51. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RVMD scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $257.47 (+25.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RVMD is in a strong uptrend. The price is approaching resistance at $211.51. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RVMD scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $257.47 (+25.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$197.33 -
$211.77
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
Protect Your Profits
Holding RVMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.1% below Wall St target ($257.47)
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$197.33 -
$211.77
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$188.18
Resistance Level
$211.51
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-34.45
Wall Street Target
$257.47
(+25.1%)
Revenue Growth (YoY)
-95.2%
Share & Embed Analysis
Last updated: October 02, 2026 7:06 AM ET
Data refreshes hourly during market hours. Next update: 8:06 AM
Data refreshes hourly during market hours. Next update: 8:06 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RVMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark A Goldsmith
SELL
120000 shares
2026-04-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$371 | 47 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 52 HOLD |
|
VRTX
Vertex Pharmaceuticals IâĻ |
BUY
34 analysts |
$570 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$310 | 69 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$63 | 59 HOLD |
Advanced RVMD Option Strategies
Professional options setups generated by AI based on today's RVMD price and gamma walls.
